LOS ANGELES, May 14, 2012 /PRNewswire-USNewswire/ — Actor and producer Michael Douglas has donated his time to help create a television public service announcement (PSA) on behalf of the Oral Cancer Foundation (OCF), a non-profit organization dedicated to helping those affected by the disease. The PSA will support the Foundation’s efforts to educate the public [...]
Continue reading...Wednesday, March 7, 2012
Source: http://news.medill.northwestern.edu/ Author: Zen Vuong “We’re at the precipice of this epidemic,” said Dr. Ezra Cohen, who specializes in head and neck cancers. The culprit is sexually-transmitted human papillomavirus-16. Human papillomavirus-positive head and neck cancer cases have been rising about 3 percent every year for the last three decades, said Cohen of The University of [...]
Continue reading...Wednesday, November 30, 2011
Source: National Cancer Institute A bellwether moment in the history of cancer prevention came in 2006 when the Food and Drug Administration (FDA) approved the first vaccine to prevent cervical cancer. The vaccine, Gardasil, protects against the two primary cancer-causing, or oncogenic, types of the human papillomavirus (HPV)—HPV-16 and HPV-18. These types are responsible for [...]
Continue reading...Tuesday, November 29, 2011
Source: National Cancer Institute End-of-trial results from a trial testing Cervarix, a vaccine against human papillomavirus (HPV) types 16 and 18, showed that the vaccine continued to provide substantial protection against cervical precancers 4 years after vaccination. Cervarix provided almost complete protection in young women who had no evidence of exposure to HPV at the [...]
Continue reading...Wednesday, April 27, 2011
Source: Dr.Bicuspid.com Researchers from Tufts University School of Medicine have developed a protein-based inhibitor that could provide a topical treatment for HPV as an alternative to surgical and harsh chemical treatments (FASEB Journal, April 11, 2011). HPV affects about 20 million people in the U.S., making it the most common sexually transmitted infection. There are [...]
Continue reading...Sunday, April 10, 2011
Source: www.dentistryiq.com Author: Nick Efthimiadis, Vice President, Sales & Marketing, LED Dental Inc. As the intense media attention surrounding Michael Douglas’s illness clearly demonstrated, oral cancer is increasingly in the news these days. With the unfortunate growth in the number of relatively young people contracting the disease due to exposure to the sexually-transmitted human papilla [...]
Continue reading...Monday, April 4, 2011
ROSEMONT, Ill., April 1, 2011 /PRNewswire-USNewswire/ — The 2011 Oral Cancer Awareness Week, set for April 11-15, is intended to educate people of all ages and socio-economic levels about the risk factors and symptoms of oral, head and neck cancer and the importance of early detection. The American Association of Oral and Maxillofacial Surgeons (AAOMS) [...]
Continue reading...Sunday, April 3, 2011
Source: www.dailymail.co.uk Author: Professor Lawrence Young The seemingly unstoppable rise of throat and mouth cancers over the past two decades has left experts baffled and deeply concerned. These are truly horrible diseases. More than 15,000 new patients are diagnosed each year in Britain alone and almost 8,000 die from the most common type, cancer of [...]
Continue reading...Monday, February 21, 2011
Source: www.dailymail.co.uk Author: staff A virus spread during oral sex is now the main cause of throat cancer in people under 50, scientists have warned. They say the human papilloma virus spread during unprotected sex is to blame for a disturbing rise in potentially deadly oral cancers in the last few decades. Doctors have called [...]
Continue reading...Tuesday, February 15, 2011
Source: www.medscape.org Author: Laurie Barclay, MD; Charles P. Vega, MD Quadrivalent human papillomavirus (HPV) vaccine may prevent infection with HPV types 6, 11, 16, and 18 and the development of related external genital lesions in young men 16 to 26 years old, according to the results of a randomized, placebo-controlled, double-blind trial reported in the [...]
Continue reading...
Monday, May 14, 2012
0 Comments